Registry Study for Symptom Management and Monitoring By PHR APP in Routine Cancer Care Practice

Registry Study for Symptom Management and Monitoring By PHR APP in Routine Cancer Care Practice - Oncology PHR Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051589

Enrollment

5000

Registered

2023-09-01

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed with a malignant tumor 2) 18 years of age or older at the time consent is obtained 3) Use or plan to use a PHR application for symptom management 4) Consent to participate in the study has been obtained in writing or electronically

Exclusion criteria

Exclusion criteria: 1) Patients who have obvious difficulty using the PHR application (with or without assistance from family, staff, etc.) 2) Patients who clearly have difficulty assessing their own symptoms due to psychiatric disorders or cognitive dysfunction.

Design outcomes

Primary

Measure	Time frame
Feasibility of the use of PHR application	—

Secondary

Measure	Time frame
Frequency of adverse events assessed by PRO-CTCAE by cancer type and treatment Change in quality of life (EORTC-C30) over time by cancer type and treatment Usefulness of PHR application Extent, satisfaction, and usefulness of information assessed by EORTC QLQ - INFO25	—

Countries

Japan

Contacts

Public ContactReiko Makihara

National Cancer Center Hospital Department of Pharmacy

reando@ncc.go.jp03-3542-2511

Outcome results